Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial.

MLA

Roberts, Matthew A., et al. “Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial.” Kidney & Blood Pressure Research, vol. 42, no. 6, 2017, pp. 1033–44. EBSCOhost, https://doi.org/10.1159/000485589.

APA

Roberts, M. A., Darssan, D., Badve, S. V., Carroll, R. P., Fahim, M. A., Haluska, B. A., Hawley, C. M., Isbel, N. M., Marshall, M. R., Pascoe, E. M., Pedagogos, E., Pilmore, H. L., Snelling, P., Stanton, T., Tan, K.-S., Tonkin, A. M., Vergara, L. A., & Ierino, F. L. (2017). Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial. Kidney & Blood Pressure Research, 42(6), 1033–1044. https://doi.org/10.1159/000485589

Chicago

Roberts, Matthew A, Darsy Darssan, Sunil V Badve, Robert P Carroll, Magid A Fahim, Brian A Haluska, Carmel M Hawley, et al. 2017. “Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial.” Kidney & Blood Pressure Research 42 (6): 1033–44. doi:10.1159/000485589.